MedPath

Urinary Catheter Self-Discontinuation After Urogynecology Surgery

Not Applicable
Recruiting
Conditions
Catheter Related Complication
Pelvic Organ Prolapse
Urinary Retention
Stress Urinary Incontinence
Interventions
Procedure: Catheter self-discontinuation
Registration Number
NCT05860634
Lead Sponsor
University of Texas at Austin
Brief Summary

The goal of this randomized clinical trial is to determine if removal of transurethral urinary catheters by patients at home is as safe as catheter removal in the office following urogynecologic surgery.

Participants will be randomized to either standard catheter removal in the office or catheter self-removal at home.

Detailed Description

This is a prospective, randomized, two-parallel arm, non-inferiority trial to evaluate two methods of catheter discontinuation in women with post-operative urinary retention (POUR) after surgery for pelvic organ prolapse (POP) or stress urinary incontinence (SUI). This study will evaluate whether self-discontinuation of transurethral catheter by patients is non-inferior to standard office discontinuation based on rates of persistent POUR on post-operative day (POD) 1.

Recruitment & Eligibility

Status
RECRUITING
Sex
Female
Target Recruitment
118
Inclusion Criteria
  1. Are at least 18 years of age
  2. Are fluent and able to read in English or Spanish
  3. Undergo POP and/or SUI surgery (uterosacral ligament suspension, sacrospinous ligament fixation, sacral colpopexy, anterior colporrhaphy, posterior colporrhaphy, and/or mid-urethral sling) that occurs on Monday - Thursday
  4. Have transurethral catheter in place at the conclusion of surgery as part of standard care
  5. Are diagnosed with POUR on POD0 based on ultrasound bladder scan PVR of 100 mL or more
  6. Are discharged home on the same day of surgery (POD 0)
Read More
Exclusion Criteria
  1. Have preoperative voiding dysfunction requiring self-catheterization or indwelling transurethral catheter
  2. Have physical or mental impairment that would impact their ability to remove their catheter themselves.
  3. Undergo urethral bulking injections as part of surgery
  4. Have undergone a planned or unplanned urinary tract procedure requiring prolonged catheterization as standard of care (e.g. cystotomy repair, ureteral reimplantation, vesicovaginal fistula repair, urethral diverticulum repair)
Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Catheter self-discontinuation groupCatheter self-discontinuationThe patients randomized to the catheter self-discontinuation group will be provided with a diagrammatic handout and will be instructed to remove their indwelling urinary catheter at home on the morning of Postoperative day 1.
Primary Outcome Measures
NameTimeMethod
Number of Participants With Postoperative Urinary RetentionPost-operative day 1

Non-inferiority comparison of the rates of persistent POUR on POD1 between catheter self-discontinuation and standard office catheter. Persistent POUR is defined as PVR greater than 100 mL by bladder scan on POD1.

Secondary Outcome Measures
NameTimeMethod
Rates of postoperative urinary tract infection (UTI)within 6 weeks of surgery

Rates of postoperative UTI within 6 weeks of surgery - UTI will be defined as treatment with antibiotics for symptoms of UTI.

Incidence of recurrent POURwithin 6 weeks of surgery

Recurrent POUR will be defined as any participant with successful POD1 voiding trial who later requires replacement of catheter due to recurrent POUR within 6 weeks of surgery. Recurrent POUR is defined as PVR greater than 100 mL by bladder scan after passing initial POD1 voiding trial.

Number of postoperative patient encounterswithin 6 weeks of surgery

Number of postoperative patient encounters, including any patient call to the office, electronic medical record message to office from patient, office visit, or emergency department visit.

Patient satisfaction assessment via the Acceptability of Intervention Measure (AIM) QuestionnairePost-operative day 1

Patient satisfaction with catheter removal method as assessed via the Acceptability of Intervention Measure (AIM) Questionnaire.

The AIM Questionnaire is a 4-item questionnaire on a 5-point Likert scale. Response Scale: 1 = Completely disagree, 2 = Disagree, 3 = Neither agree nor disagree, 4 = Agree, 5 = Completely agree Scoring Instructions: Scale is created by averaging responses. Scale values range from 1 to 5.

The higher the score is, the higher the degree the patient finds the intervention acceptable.

Patient satisfaction assessment via the the Surgical Satisfaction Questionnaire - 8 (SSQ-8).Post-operative day 1

Patient satisfaction with catheter removal method as assessed via the Surgical Satisfaction Questionnaire - 8 (SSQ-8).

The SSQ-8 is an 8-item questionnaire, with responses recorded on a 5-point Likert scale with responses from 0 "Very Unsatisfied" to 4 "Very Satisfied." Scoring uses the mean average of the 8 scores being multiplied by 25 (the questionnaire is considered incomplete if more than 2 items are not answered), yielding a potential range of scores from 0 to 100. The higher the score is, the greater the degree of surgical satisfaction.

Trial Locations

Locations (4)

Seton Medical Center Austin

🇺🇸

Austin, Texas, United States

Seton Medical Center Williamson

🇺🇸

Round Rock, Texas, United States

University of Texas of Austin - Dell Seton Medical Center

🇺🇸

Austin, Texas, United States

Ascension Seton Hays Hospital

🇺🇸

Kyle, Texas, United States

© Copyright 2025. All Rights Reserved by MedPath